Advertisement
U.S. Markets close in 1 hr 35 mins

Immunic, Inc. (IMUX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
1.2000+0.0200 (+1.69%)
As of 02:23PM EST. Market open.
Full screen
Loading interactive chart...
  • Associated Press Finance

    Immunic: Q3 Earnings Snapshot

    NEW YORK (AP) — Immunic, Inc. IMUX) on Thursday reported a loss of $24.4 million in its third quarter. On a per-share basis, the New York-based company said it had a loss of 24 cents.

  • PR Newswire

    Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced financial results for the third quarter and nine months ended September 30, 2024, and provided a corporate update.